The dopamine transporter and dopamine D2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons

[1]  D. Mash,et al.  Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons , 1994, Annals of neurology.

[2]  Y. Agid,et al.  Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon. , 1994, Brain research. Molecular brain research.

[3]  S. Kish,et al.  Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding. , 1994, Molecular pharmacology.

[4]  P. McKenna,et al.  Co-expression of dopamine transporter mRNA and tyrosine hydroxylase mRNA in ventral mesencephalic neurones. , 1993, Brain research. Molecular brain research.

[5]  M. Herkenham,et al.  Molecular alterations in the neostriatum of human cocaine addicts , 1993, Synapse.

[6]  M. Herkenham,et al.  Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. , 1992, Brain research. Molecular brain research.

[7]  C. Gerfen.  The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. , 1992, Annual review of neuroscience.

[8]  S. Amara,et al.  Cloning and expression of a cocaine-sensitive rat dopamine transporter. , 1991, Science.

[9]  W. Gibb,et al.  Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[10]  G. Paxinos,et al.  Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography , 1991, The Journal of comparative neurology.

[11]  A. Horn.  Dopamine uptake: A review of progress in the last decade , 1990, Progress in Neurobiology.

[12]  M. Caron,et al.  Molecular cloning and expression of the gene for a human D1 dopamine receptor , 1990, Nature.

[13]  M Goldstein,et al.  Comparison of gene expression of the dopamine D-2 receptor and DARPP-32 in rat brain, pituitary and adrenal gland. , 1990, European journal of pharmacology.

[14]  Y. Agid,et al.  Tyrosine hydroxylase gene expression in human ventral mesencephalon: Detection of tyrosine hydroxylase messenger RNA in neurites , 1990, Journal of Neuroscience Research.

[15]  C. Gerfen,et al.  Multiple D2 dopamine receptors produced by alternative RNA splicing , 1989, Nature.

[16]  D. Grandy,et al.  Cloning of the cDNA and gene for a human D2 dopamine receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Graybiel,et al.  Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Graybiel,et al.  Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum , 1989, Brain Research.

[19]  J. Haycock,et al.  Ventral mesencephalic neurons containing both cholecystokinin‐ and tyrosine hydroxylase‐like immunoreactivities project to forebrain regions , 1989, The Journal of comparative neurology.

[20]  R. Roth,et al.  Telencephalic Projections of the A8 Dopamine Cell Group , 1988, Annals of the New York Academy of Sciences.

[21]  A. Graybiel,et al.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.

[22]  L. Chiodo.  Dopamine-containing neurons in the mammalian central nervous system: Electrophysiology and pharmacology , 1988, Neuroscience & Biobehavioral Reviews.

[23]  R. Roth,et al.  Nigrostriatal dopamine neurons: Modulation of impulse-induced activation of tyrosine hydroxylation by dopamine autoreceptors , 1987, Neuropharmacology.

[24]  J. Mallet,et al.  A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics , 1987, Nature.

[25]  C. D. Stern,et al.  Handbook of Chemical Neuroanatomy Methods in Chemical Neuroanatomy. Edited by A. Bjorklund and T. Hokfelt. Elsevier, Amsterdam, 1983. Cloth bound, 548 pp. UK £140. (Volume 1 in the series). , 1986, Neurochemistry International.

[26]  T. Murotsu,et al.  Structure of human cholecystokinin gene and its chromosomal location. , 1986, Gene.

[27]  P. Mitchell,et al.  Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis , 1985, British journal of pharmacology.

[28]  R. Deschenes,et al.  Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[29]  F. J. White,et al.  Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. , 1983, Science.

[30]  M. Herkenham,et al.  Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum , 1981, Nature.

[31]  R. Roth,et al.  Mesocortical dopamine neurons. Lack of autoreceptors modulating dopamine synthesis. , 1981, Molecular pharmacology.